Important

The National Multiple Sclerosis Society has announced Katerina Akassoglou, Ph.D., a leading researcher at the Gladstone Institute of Neurological Disease and the Department of...

Rhonda Voskuhl, M.D., University of California, Los Angeles, to present keynote address at ACTRIMS Forum 2019MADISON, Wis., November 27, 2018 – Multiple sclerosis is...

I have been living with Primary Progressive Multiple Sclerosis Active (PPMS active) for 40 years, since I was 8 years old.  PPMS active is...

Zinbryta (daizumab) was flagged by European regulators with a lethal safety warning over cases of encephalitis and meningoencephalitis. Evaluating the drug's "complex and evolving...

Therapeutic Targets in MS: The Frontier and the Future of Disease Modifying TherapyMadison, Wis., Feb. 14, 2018 – The Americas Committee for Treatment and...

SAN DIEGO — The third annual forum of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), to be held here February...

New Zealand - The Chief Coroner is warning New Zealanders with multiple sclerosis to take care in the heat after a Christchurch woman died after...

I had the pleasure of interviewing Dr. Travis Stiles CEO of Novoron Bioscience, Inc. Novoron is a private biotech company developing novel therapeutic approaches in...

Transform is the annual health care innovation conference that brings together decision makers, change agents, and stakeholders from around the world. We challenge assumptions,...

In this video, Dr Vilija Jokubaitis introduces us to the research she is undertaking using MSBase, a Neuro-Immunology Registry used by multiple sclerosis researchers...